| Name | Title | Contact Details |
|---|---|---|
Mike McSherry |
Chief Executive Officer | Profile |
Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer Sectors to create biologically-based products that improve the quality of life and the health of the planet. Through the company’s proprietary UltraVector® platform and and suite of technologies, Intrexon provides its partners with industrial-scale design and development of complex biological systems. The UltraVector® platform delivers unprecedented control over the quality, function, and performance of living cells. We call our synthetic biology approach and integrated technologies Better DNA®, and we invite you to discover more at www.DNA.com.
MEDO USA is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
GEMCare Health Plan is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Chem Rx Corporation, formerly Paramount Acquisition Corp., provides institutional pharmacy services to skilled nursing facilities, assisted living facilities, residential living facilities, addiction treatment centers and other long-term healthcare
Bioexpressions is a Mill Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.